ID

41409

Descripción

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02240238

Link

https://clinicaltrials.gov/show/NCT02240238

Palabras clave

Versiones (3)
  1. 19/1/19 19/1/19 -
  2. 28/9/20 28/9/20 -
  3. 1/10/20 1/10/20 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

1 de octubre de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Solid Tumors, NSCLC, Biliary and Bladder Cancer NCT02240238

Inglés

Eligibility Solid Tumors, NSCLC, Biliary and Bladder Cancer NCT02240238

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
(part 1 only) have a histologically or cytologically confirmed diagnosis of advanced solid tumor that has relapsed or is refractory to standard curative or palliative therapy or has a contraindication to standard therapy.
Descripción

Histologically or cytologically confirmed advanced solid neoplasms, recurrent, unresponsive to treatment or with contraindication to standard therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0280100
UMLS CUI [1,2]
C0277556
UMLS CUI [2,1]
C0280100
UMLS CUI [2,2]
C0205269
UMLS CUI [3,1]
C0280100
UMLS CUI [3,2]
C1301624
UMLS CUI [3,3]
C1442989
UMLS CUI [3,4]
C0087111
UMLS CUI [4,1]
C0280100
UMLS CUI [4,2]
C1300072
UMLS CUI [5,1]
C0280100
UMLS CUI [5,2]
C0449575
UMLS CUI [6,1]
C0280100
UMLS CUI [6,2]
C1265900
(part 2 only) have histologically or cytologically confirmed diagnosis of stage iiib or iv nsclc and have received 1 or 2 lines of prior chemotherapy or targeted therapy for stage iiib or iv nsclc (second- or third-line).
Descripción

Histologically or cytologically confirmed NSCLC stage iiiv or iv after prior chemotherapy or targeted therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0449575
UMLS CUI [2,1]
C0007131
UMLS CUI [2,2]
C1265900
UMLS CUI [3,1]
C0007131
UMLS CUI [3,2]
C1300072
UMLS CUI [4,1]
C0007131
UMLS CUI [4,2]
C1514457
UMLS CUI [5,1]
C0007131
UMLS CUI [5,2]
C1514463
UMLS CUI [5,3]
C2985566
have measurable disease per response evaluation criteria in solid tumors (recist) version 1.1.
Descripción

Measurable Disease (recist)

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1709926
UMLS CUI [2]
C1513041
eastern cooperative oncology group (ecog) performance status of 0 to 1
Descripción

Ecog performance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
have adequate bone marrow reserve, liver function, and renal function
Descripción

Adequate bone marrow reserve, liver and renal function

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
have received prior platinum therapy in the past 3 months
Descripción

Recent platinum therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3536920
UMLS CUI [1,2]
C0332185
have received prior cisplatin and gemcitabine concomitantly within the last 6 months or are refractory to cisplatin and gemcitabine.
Descripción

Recent therapy with or refractory to cisplatin and gemcitabine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0338265
UMLS CUI [1,2]
C0332185
UMLS CUI [2,1]
C0338265
UMLS CUI [2,2]
C0205269
unresolved toxicity from prior radiation, chemotherapy, or other targeted treatment, including investigational treatment
Descripción

Unresolved toxicity from radio-, chemo- or other targeted therapy like investigational therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C0443342
UMLS CUI [1,3]
C0279134
UMLS CUI [2,1]
C0600688
UMLS CUI [2,2]
C0443342
UMLS CUI [2,3]
C1514457
UMLS CUI [3,1]
C0600688
UMLS CUI [3,2]
C0443342
UMLS CUI [3,3]
C1514463
UMLS CUI [3,4]
C2985566
UMLS CUI [4,1]
C0600688
UMLS CUI [4,2]
C0443342
UMLS CUI [4,3]
C1514463
UMLS CUI [4,4]
C0949266
pregnant or breast feeding
Descripción

Pregnant, breast feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Volver a la parte superior de la página

Similar models

Eligibility Solid Tumors, NSCLC, Biliary and Bladder Cancer NCT02240238

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Histologically or cytologically confirmed advanced solid neoplasms, recurrent, unresponsive to treatment or with contraindication to standard therapy
Item
(part 1 only) have a histologically or cytologically confirmed diagnosis of advanced solid tumor that has relapsed or is refractory to standard curative or palliative therapy or has a contraindication to standard therapy.
boolean
C0280100 (UMLS CUI [1,1])
C0277556 (UMLS CUI [1,2])
C0280100 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
C0280100 (UMLS CUI [3,1])
C1301624 (UMLS CUI [3,2])
C1442989 (UMLS CUI [3,3])
C0087111 (UMLS CUI [3,4])
C0280100 (UMLS CUI [4,1])
C1300072 (UMLS CUI [4,2])
C0280100 (UMLS CUI [5,1])
C0449575 (UMLS CUI [5,2])
C0280100 (UMLS CUI [6,1])
C1265900 (UMLS CUI [6,2])
Histologically or cytologically confirmed NSCLC stage iiiv or iv after prior chemotherapy or targeted therapy
Item
(part 2 only) have histologically or cytologically confirmed diagnosis of stage iiib or iv nsclc and have received 1 or 2 lines of prior chemotherapy or targeted therapy for stage iiib or iv nsclc (second- or third-line).
boolean
C0007131 (UMLS CUI [1,1])
C0449575 (UMLS CUI [1,2])
C0007131 (UMLS CUI [2,1])
C1265900 (UMLS CUI [2,2])
C0007131 (UMLS CUI [3,1])
C1300072 (UMLS CUI [3,2])
C0007131 (UMLS CUI [4,1])
C1514457 (UMLS CUI [4,2])
C0007131 (UMLS CUI [5,1])
C1514463 (UMLS CUI [5,2])
C2985566 (UMLS CUI [5,3])
Measurable Disease (recist)
Item
have measurable disease per response evaluation criteria in solid tumors (recist) version 1.1.
boolean
C1709926 (UMLS CUI [1])
C1513041 (UMLS CUI [2])
Ecog performance
Item
eastern cooperative oncology group (ecog) performance status of 0 to 1
boolean
C1520224 (UMLS CUI [1])
Adequate bone marrow reserve, liver and renal function
Item
have adequate bone marrow reserve, liver function, and renal function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Recent platinum therapy
Item
have received prior platinum therapy in the past 3 months
boolean
C3536920 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Recent therapy with or refractory to cisplatin and gemcitabine
Item
have received prior cisplatin and gemcitabine concomitantly within the last 6 months or are refractory to cisplatin and gemcitabine.
boolean
C0338265 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0338265 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
Unresolved toxicity from radio-, chemo- or other targeted therapy like investigational therapy
Item
unresolved toxicity from prior radiation, chemotherapy, or other targeted treatment, including investigational treatment
boolean
C0600688 (UMLS CUI [1,1])
C0443342 (UMLS CUI [1,2])
C0279134 (UMLS CUI [1,3])
C0600688 (UMLS CUI [2,1])
C0443342 (UMLS CUI [2,2])
C1514457 (UMLS CUI [2,3])
C0600688 (UMLS CUI [3,1])
C0443342 (UMLS CUI [3,2])
C1514463 (UMLS CUI [3,3])
C2985566 (UMLS CUI [3,4])
C0600688 (UMLS CUI [4,1])
C0443342 (UMLS CUI [4,2])
C1514463 (UMLS CUI [4,3])
C0949266 (UMLS CUI [4,4])
Pregnant, breast feeding
Item
pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial